

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic metaphase plate congression (GO:0007080) | 4.58818264 |
| 2 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.36830575 |
| 3 | nucleobase biosynthetic process (GO:0046112) | 4.26947563 |
| 4 | DNA unwinding involved in DNA replication (GO:0006268) | 4.22963016 |
| 5 | protein localization to kinetochore (GO:0034501) | 4.20980791 |
| 6 | IMP biosynthetic process (GO:0006188) | 4.05645761 |
| 7 | mitotic nuclear envelope disassembly (GO:0007077) | 4.03246214 |
| 8 | nuclear pore organization (GO:0006999) | 4.02505216 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.97588880 |
| 10 | purine nucleobase biosynthetic process (GO:0009113) | 3.97453252 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 3.96125869 |
| 12 | metaphase plate congression (GO:0051310) | 3.94277424 |
| 13 | mitotic chromosome condensation (GO:0007076) | 3.91502632 |
| 14 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.86500879 |
| 15 | CENP-A containing nucleosome assembly (GO:0034080) | 3.84241043 |
| 16 | chromatin remodeling at centromere (GO:0031055) | 3.78459729 |
| 17 | nuclear pore complex assembly (GO:0051292) | 3.77681114 |
| 18 | DNA strand elongation (GO:0022616) | 3.75844196 |
| 19 | kinetochore organization (GO:0051383) | 3.75618106 |
| 20 | nuclear envelope disassembly (GO:0051081) | 3.74299652 |
| 21 | membrane disassembly (GO:0030397) | 3.74299652 |
| 22 | ribosome biogenesis (GO:0042254) | 3.73586726 |
| 23 | ribosomal small subunit assembly (GO:0000028) | 3.72353644 |
| 24 | protein localization to chromosome, centromeric region (GO:0071459) | 3.69660994 |
| 25 | mitotic sister chromatid segregation (GO:0000070) | 3.69285061 |
| 26 | IMP metabolic process (GO:0046040) | 3.67990373 |
| 27 | ribosome assembly (GO:0042255) | 3.66294114 |
| 28 | DNA replication initiation (GO:0006270) | 3.65532846 |
| 29 | DNA replication checkpoint (GO:0000076) | 3.59830673 |
| 30 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53552074 |
| 31 | establishment of chromosome localization (GO:0051303) | 3.52817448 |
| 32 | cullin deneddylation (GO:0010388) | 3.49995763 |
| 33 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.48599584 |
| 34 | DNA replication-independent nucleosome organization (GO:0034724) | 3.48599584 |
| 35 | protein deneddylation (GO:0000338) | 3.47468675 |
| 36 | folic acid metabolic process (GO:0046655) | 3.45466329 |
| 37 | sister chromatid segregation (GO:0000819) | 3.40422384 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 3.39446503 |
| 39 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.38497925 |
| 40 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.38497925 |
| 41 | regulation of spindle organization (GO:0090224) | 3.34782618 |
| 42 | kinetochore assembly (GO:0051382) | 3.34351593 |
| 43 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.32963748 |
| 44 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.32707409 |
| 45 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.22782454 |
| 46 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.22478756 |
| 47 | telomere maintenance via recombination (GO:0000722) | 3.22336093 |
| 48 | mitotic sister chromatid cohesion (GO:0007064) | 3.21989434 |
| 49 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.21165428 |
| 50 | non-recombinational repair (GO:0000726) | 3.21165428 |
| 51 | histone exchange (GO:0043486) | 3.19148132 |
| 52 | tetrahydrofolate metabolic process (GO:0046653) | 3.18843819 |
| 53 | pseudouridine synthesis (GO:0001522) | 3.18357713 |
| 54 | dosage compensation (GO:0007549) | 3.17198333 |
| 55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.15868011 |
| 56 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.15436430 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.13918335 |
| 58 | mitotic recombination (GO:0006312) | 3.13346128 |
| 59 | regulation of helicase activity (GO:0051095) | 3.11925743 |
| 60 | meiotic chromosome segregation (GO:0045132) | 3.10623254 |
| 61 | tRNA aminoacylation for protein translation (GO:0006418) | 3.10060200 |
| 62 | DNA deamination (GO:0045006) | 3.09649299 |
| 63 | establishment of viral latency (GO:0019043) | 3.04464992 |
| 64 | tRNA aminoacylation (GO:0043039) | 2.99828913 |
| 65 | amino acid activation (GO:0043038) | 2.99828913 |
| 66 | glycine metabolic process (GO:0006544) | 2.97305652 |
| 67 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.97282619 |
| 68 | negative regulation of ligase activity (GO:0051352) | 2.97282619 |
| 69 | rRNA processing (GO:0006364) | 2.96075138 |
| 70 | DNA ligation (GO:0006266) | 2.95262908 |
| 71 | DNA duplex unwinding (GO:0032508) | 2.93060560 |
| 72 | nuclear envelope organization (GO:0006998) | 2.92992630 |
| 73 | folic acid-containing compound metabolic process (GO:0006760) | 2.92877211 |
| 74 | regulation of translation in response to stress (GO:0043555) | 2.91577116 |
| 75 | DNA geometric change (GO:0032392) | 2.91407203 |
| 76 | establishment of integrated proviral latency (GO:0075713) | 2.90159584 |
| 77 | ribosomal large subunit biogenesis (GO:0042273) | 2.89076453 |
| 78 | rRNA metabolic process (GO:0016072) | 2.88596508 |
| 79 | telomere maintenance via telomere lengthening (GO:0010833) | 2.88504841 |
| 80 | protein localization to chromosome (GO:0034502) | 2.86202378 |
| 81 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.85956544 |
| 82 | maturation of 5.8S rRNA (GO:0000460) | 2.85453992 |
| 83 | chromatin assembly or disassembly (GO:0006333) | 2.84613316 |
| 84 | spindle checkpoint (GO:0031577) | 2.84316418 |
| 85 | rRNA modification (GO:0000154) | 2.84231163 |
| 86 | oxidative phosphorylation (GO:0006119) | 2.83970490 |
| 87 | transcription from mitochondrial promoter (GO:0006390) | 2.81645081 |
| 88 | proteasome assembly (GO:0043248) | 2.80546738 |
| 89 | regulation of chromosome segregation (GO:0051983) | 2.80230439 |
| 90 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.79865656 |
| 91 | regulation of translational termination (GO:0006449) | 2.78287161 |
| 92 | spindle assembly checkpoint (GO:0071173) | 2.77075608 |
| 93 | pore complex assembly (GO:0046931) | 2.75278060 |
| 94 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.75191812 |
| 95 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.74818243 |
| 96 | negative regulation of histone methylation (GO:0031061) | 2.74298181 |
| 97 | serine family amino acid biosynthetic process (GO:0009070) | 2.74018858 |
| 98 | positive regulation of chromosome segregation (GO:0051984) | 2.74013627 |
| 99 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.73738280 |
| 100 | negative regulation of sister chromatid segregation (GO:0033046) | 2.73738280 |
| 101 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.73738280 |
| 102 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.73738280 |
| 103 | spliceosomal snRNP assembly (GO:0000387) | 2.73488924 |
| 104 | negative regulation of chromosome segregation (GO:0051985) | 2.73265750 |
| 105 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.72715970 |
| 106 | positive regulation of ligase activity (GO:0051351) | 2.72058322 |
| 107 | mitotic spindle assembly checkpoint (GO:0007094) | 2.71457284 |
| 108 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.71220760 |
| 109 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.71220760 |
| 110 | regulation of centrosome cycle (GO:0046605) | 2.70251292 |
| 111 | regulation of mitotic spindle organization (GO:0060236) | 2.69793067 |
| 112 | chromosome segregation (GO:0007059) | 2.68649895 |
| 113 | translational initiation (GO:0006413) | 2.68629599 |
| 114 | L-serine metabolic process (GO:0006563) | 2.67721694 |
| 115 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.67482667 |
| 116 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.67057096 |
| 117 | viral mRNA export from host cell nucleus (GO:0046784) | 2.66749796 |
| 118 | mitochondrial RNA metabolic process (GO:0000959) | 2.66743159 |
| 119 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.66428336 |
| 120 | isotype switching (GO:0045190) | 2.66428336 |
| 121 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.66428336 |
| 122 | ATP-dependent chromatin remodeling (GO:0043044) | 2.65625913 |
| 123 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.65464249 |
| 124 | mitotic spindle checkpoint (GO:0071174) | 2.65287455 |
| 125 | rRNA methylation (GO:0031167) | 2.64790015 |
| 126 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.62435532 |
| 127 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.60864400 |
| 128 | regulation of ligase activity (GO:0051340) | 2.60666940 |
| 129 | negative regulation of DNA recombination (GO:0045910) | 2.60137136 |
| 130 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.59825586 |
| 131 | histone mRNA metabolic process (GO:0008334) | 2.57307528 |
| 132 | de novo protein folding (GO:0006458) | 2.56387238 |
| 133 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.55862890 |
| 134 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.55862890 |
| 135 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.54837520 |
| 136 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.53488297 |
| 137 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.53488297 |
| 138 | regulation of sister chromatid segregation (GO:0033045) | 2.53488297 |
| 139 | tricarboxylic acid cycle (GO:0006099) | 2.51219082 |
| 140 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.47750482 |
| 141 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.47750482 |
| 142 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.47750482 |
| 143 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.47683146 |
| 144 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.47461021 |
| 145 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.47349198 |
| 146 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.47349198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.83150603 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.14542229 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.03113899 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.63784784 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.62543677 |
| 6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.20897516 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.83139277 |
| 8 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.76727237 |
| 9 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.73830033 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.73028088 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.62999804 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58911866 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.47146006 |
| 14 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.46149105 |
| 15 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.41498758 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.40145057 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33855585 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.30982123 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.23595471 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.18982001 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.11811988 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.08121964 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.03858519 |
| 24 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.02232191 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93511588 |
| 26 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.92868719 |
| 27 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.92647370 |
| 28 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.92574446 |
| 29 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.89050053 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88781405 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.85789005 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84806609 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81969594 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.80111809 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.75425917 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.74373047 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69057814 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67448222 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64677221 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.63967032 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.61150560 |
| 42 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60067367 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.60026238 |
| 44 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.59532662 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58062740 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56744778 |
| 47 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.56454018 |
| 48 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54349113 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53006800 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48544162 |
| 51 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.47801057 |
| 52 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.45024240 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42745629 |
| 54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39059202 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37663173 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37487660 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31154419 |
| 58 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.30845803 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30241040 |
| 60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29461730 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28256707 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28002995 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27951491 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27275929 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25445419 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24904732 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23683516 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16279618 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15657182 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15462624 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12447200 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12106815 |
| 73 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11848100 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09580597 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08902850 |
| 76 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.07275439 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06697140 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06268403 |
| 79 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05942726 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04929533 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04799911 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03180985 |
| 83 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02605906 |
| 84 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01050732 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99643767 |
| 86 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.99030804 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98941777 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.98139255 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98107143 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97834719 |
| 91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92653819 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92424833 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91353408 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91224060 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88496290 |
| 96 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88366943 |
| 97 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88050914 |
| 98 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87421631 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.86889324 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 0.86008145 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85951754 |
| 102 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85718547 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84753598 |
| 104 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84660638 |
| 105 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84060235 |
| 106 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.82784189 |
| 107 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82106396 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80874163 |
| 109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80370596 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 0.79936096 |
| 111 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78225024 |
| 112 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77894484 |
| 113 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77803398 |
| 114 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.77443151 |
| 115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77243782 |
| 116 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76654478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.81651525 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.06760892 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.91023823 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.73673598 |
| 5 | MP0003077_abnormal_cell_cycle | 3.61603452 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.41225243 |
| 7 | MP0008057_abnormal_DNA_replication | 3.02905244 |
| 8 | MP0008058_abnormal_DNA_repair | 2.84870293 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.59922770 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.52122963 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.35797092 |
| 12 | MP0001730_embryonic_growth_arrest | 2.23293499 |
| 13 | MP0010307_abnormal_tumor_latency | 2.20681748 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.12300245 |
| 15 | MP0000350_abnormal_cell_proliferation | 2.06114317 |
| 16 | MP0003186_abnormal_redox_activity | 1.99688580 |
| 17 | MP0008932_abnormal_embryonic_tissue | 1.93937075 |
| 18 | MP0003718_maternal_effect | 1.89283983 |
| 19 | MP0005360_urolithiasis | 1.89109523 |
| 20 | MP0005083_abnormal_biliary_tract | 1.87822364 |
| 21 | MP0005451_abnormal_body_composition | 1.85596474 |
| 22 | MP0003123_paternal_imprinting | 1.72645297 |
| 23 | MP0003941_abnormal_skin_development | 1.70557864 |
| 24 | MP0003786_premature_aging | 1.61930460 |
| 25 | MP0008877_abnormal_DNA_methylation | 1.58994479 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.57361691 |
| 27 | MP0005380_embryogenesis_phenotype | 1.56510212 |
| 28 | MP0001672_abnormal_embryogenesis/_devel | 1.56510212 |
| 29 | MP0000490_abnormal_crypts_of | 1.54759762 |
| 30 | MP0001697_abnormal_embryo_size | 1.54313321 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.52648734 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.49688923 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.49410550 |
| 34 | MP0003984_embryonic_growth_retardation | 1.45977534 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.43881994 |
| 36 | MP0002019_abnormal_tumor_incidence | 1.43719146 |
| 37 | MP0002088_abnormal_embryonic_growth/wei | 1.43088469 |
| 38 | MP0002080_prenatal_lethality | 1.43033692 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.42309293 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.36137694 |
| 41 | MP0000313_abnormal_cell_death | 1.35941549 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.35678692 |
| 43 | MP0006054_spinal_hemorrhage | 1.33651785 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.33362534 |
| 45 | MP0003011_delayed_dark_adaptation | 1.29454403 |
| 46 | MP0002086_abnormal_extraembryonic_tissu | 1.29395914 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.28998639 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.28931241 |
| 49 | MP0004233_abnormal_muscle_weight | 1.28034276 |
| 50 | MP0002398_abnormal_bone_marrow | 1.25869437 |
| 51 | MP0001764_abnormal_homeostasis | 1.24399902 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.23689337 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.23689337 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.22384509 |
| 55 | MP0005365_abnormal_bile_salt | 1.21546320 |
| 56 | MP0004197_abnormal_fetal_growth/weight/ | 1.20942347 |
| 57 | MP0002085_abnormal_embryonic_tissue | 1.15558487 |
| 58 | MP0001853_heart_inflammation | 1.15101627 |
| 59 | MP0002722_abnormal_immune_system | 1.14494263 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.13849695 |
| 61 | MP0001727_abnormal_embryo_implantation | 1.13051364 |
| 62 | MP0002084_abnormal_developmental_patter | 1.11744984 |
| 63 | MP0003646_muscle_fatigue | 1.07237199 |
| 64 | MP0009697_abnormal_copulation | 1.05142806 |
| 65 | MP0001293_anophthalmia | 1.02589665 |
| 66 | MP0000598_abnormal_liver_morphology | 1.02308506 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.00885729 |
| 68 | MP0002429_abnormal_blood_cell | 0.98940005 |
| 69 | MP0009840_abnormal_foam_cell | 0.98853343 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.97664228 |
| 71 | MP0005000_abnormal_immune_tolerance | 0.96431805 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.96152857 |
| 73 | MP0001835_abnormal_antigen_presentation | 0.95963545 |
| 74 | MP0008260_abnormal_autophagy | 0.93919244 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.92967061 |
| 76 | MP0001800_abnormal_humoral_immune | 0.92500120 |
| 77 | MP0009672_abnormal_birth_weight | 0.92457358 |
| 78 | MP0002132_abnormal_respiratory_system | 0.91498848 |
| 79 | MP0009053_abnormal_anal_canal | 0.90160876 |
| 80 | MP0001119_abnormal_female_reproductive | 0.89356615 |
| 81 | MP0003890_abnormal_embryonic-extraembry | 0.88536808 |
| 82 | MP0000716_abnormal_immune_system | 0.88396285 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.88294047 |
| 84 | MP0002419_abnormal_innate_immunity | 0.88209953 |
| 85 | MP0001915_intracranial_hemorrhage | 0.87991959 |
| 86 | MP0003436_decreased_susceptibility_to | 0.87921896 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87799176 |
| 88 | MP0000609_abnormal_liver_physiology | 0.87154149 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.87110783 |
| 90 | MP0000358_abnormal_cell_content/ | 0.85336899 |
| 91 | MP0005330_cardiomyopathy | 0.84913180 |
| 92 | MP0002006_tumorigenesis | 0.83927963 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.83712955 |
| 94 | MP0002210_abnormal_sex_determination | 0.83438572 |
| 95 | MP0005408_hypopigmentation | 0.83375402 |
| 96 | MP0000858_altered_metastatic_potential | 0.82759333 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.82676407 |
| 98 | MP0005266_abnormal_metabolism | 0.81256145 |
| 99 | MP0003303_peritoneal_inflammation | 0.80483338 |
| 100 | MP0005621_abnormal_cell_physiology | 0.80108775 |
| 101 | MP0005671_abnormal_response_to | 0.80048170 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.79920792 |
| 103 | MP0005384_cellular_phenotype | 0.78801440 |
| 104 | MP0009763_increased_sensitivity_to | 0.77074081 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.77045166 |
| 106 | MP0001145_abnormal_male_reproductive | 0.76678330 |
| 107 | MP0000653_abnormal_sex_gland | 0.75022952 |
| 108 | MP0009764_decreased_sensitivity_to | 0.74577924 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.74432595 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.74314227 |
| 111 | MP0002102_abnormal_ear_morphology | 0.73684468 |
| 112 | MP0005023_abnormal_wound_healing | 0.72900606 |
| 113 | MP0003121_genomic_imprinting | 0.71456575 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.71148963 |
| 115 | MP0005310_abnormal_salivary_gland | 0.71049611 |
| 116 | MP0008004_abnormal_stomach_pH | 0.70619277 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.69837878 |
| 118 | MP0005395_other_phenotype | 0.69208385 |
| 119 | MP0001929_abnormal_gametogenesis | 0.67708548 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.67598183 |
| 121 | MP0002723_abnormal_immune_serum | 0.66891907 |
| 122 | MP0009785_altered_susceptibility_to | 0.66747782 |
| 123 | MP0002405_respiratory_system_inflammati | 0.66558883 |
| 124 | MP0004147_increased_porphyrin_level | 0.65807989 |
| 125 | MP0002420_abnormal_adaptive_immunity | 0.65480458 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.65433791 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.64932445 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.64662522 |
| 129 | MP0001819_abnormal_immune_cell | 0.64578509 |
| 130 | MP0003315_abnormal_perineum_morphology | 0.62758334 |
| 131 | MP0002138_abnormal_hepatobiliary_system | 0.62697524 |
| 132 | MP0010329_abnormal_lipoprotein_level | 0.61459514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of anterior horn cells (HP:0002398) | 4.04685825 |
| 2 | Abnormality of the anterior horn cell (HP:0006802) | 4.04685825 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 4.01080708 |
| 4 | Microvesicular hepatic steatosis (HP:0001414) | 3.39214478 |
| 5 | Oral leukoplakia (HP:0002745) | 3.29387031 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 3.23282081 |
| 7 | Ragged-red muscle fibers (HP:0003200) | 3.22367566 |
| 8 | Breast hypoplasia (HP:0003187) | 3.07470447 |
| 9 | Multiple enchondromatosis (HP:0005701) | 3.04312411 |
| 10 | Cholecystitis (HP:0001082) | 3.03220710 |
| 11 | Abnormal gallbladder physiology (HP:0012438) | 3.03220710 |
| 12 | Reticulocytopenia (HP:0001896) | 2.96604902 |
| 13 | Progressive muscle weakness (HP:0003323) | 2.96516123 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.93200477 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 2.93158354 |
| 16 | Impulsivity (HP:0100710) | 2.91331235 |
| 17 | 11 pairs of ribs (HP:0000878) | 2.90583132 |
| 18 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.86047112 |
| 19 | Aplastic anemia (HP:0001915) | 2.85859654 |
| 20 | Progressive external ophthalmoplegia (HP:0000590) | 2.79369408 |
| 21 | Colon cancer (HP:0003003) | 2.78598490 |
| 22 | Rhabdomyosarcoma (HP:0002859) | 2.68894927 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 2.63175607 |
| 24 | Selective tooth agenesis (HP:0001592) | 2.60734089 |
| 25 | Carpal bone hypoplasia (HP:0001498) | 2.59719376 |
| 26 | IgM deficiency (HP:0002850) | 2.59336191 |
| 27 | Thrombocytosis (HP:0001894) | 2.52899697 |
| 28 | Agnosia (HP:0010524) | 2.52772186 |
| 29 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.52257030 |
| 30 | Patellar aplasia (HP:0006443) | 2.51896898 |
| 31 | Myelodysplasia (HP:0002863) | 2.51279230 |
| 32 | Chromsome breakage (HP:0040012) | 2.47073620 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 2.44762154 |
| 34 | Progressive inability to walk (HP:0002505) | 2.43160538 |
| 35 | Abnormality of chromosome stability (HP:0003220) | 2.42921978 |
| 36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.42774547 |
| 37 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.42774547 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.42774547 |
| 39 | Abnormal glycosylation (HP:0012345) | 2.42774547 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40133029 |
| 41 | Increased serum lactate (HP:0002151) | 2.38025042 |
| 42 | Entropion (HP:0000621) | 2.35802719 |
| 43 | Rhabdomyolysis (HP:0003201) | 2.32414690 |
| 44 | Hyperglycinemia (HP:0002154) | 2.32253180 |
| 45 | Rough bone trabeculation (HP:0100670) | 2.30508529 |
| 46 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.29062538 |
| 47 | Shoulder girdle muscle weakness (HP:0003547) | 2.26646494 |
| 48 | Abnormal hair whorl (HP:0010721) | 2.25378746 |
| 49 | Basal cell carcinoma (HP:0002671) | 2.23994940 |
| 50 | Abnormality of the calcaneus (HP:0008364) | 2.23318702 |
| 51 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23056801 |
| 52 | Petechiae (HP:0000967) | 2.22664937 |
| 53 | Abnormality of the preputium (HP:0100587) | 2.18973932 |
| 54 | Spastic diplegia (HP:0001264) | 2.18755673 |
| 55 | Upper limb muscle weakness (HP:0003484) | 2.18422172 |
| 56 | IgA deficiency (HP:0002720) | 2.17918451 |
| 57 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.17761436 |
| 58 | Medulloblastoma (HP:0002885) | 2.17565186 |
| 59 | Premature ovarian failure (HP:0008209) | 2.17535071 |
| 60 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.17104612 |
| 61 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.17104612 |
| 62 | Exercise-induced muscle cramps (HP:0003710) | 2.16720669 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.16534144 |
| 64 | Bone marrow hypocellularity (HP:0005528) | 2.16086677 |
| 65 | Cerebral hypomyelination (HP:0006808) | 2.16070875 |
| 66 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.15795309 |
| 67 | Secondary amenorrhea (HP:0000869) | 2.15006811 |
| 68 | Squamous cell carcinoma (HP:0002860) | 2.12607333 |
| 69 | Volvulus (HP:0002580) | 2.12516531 |
| 70 | Cellular immunodeficiency (HP:0005374) | 2.11093267 |
| 71 | Irregular epiphyses (HP:0010582) | 2.10960469 |
| 72 | Nausea (HP:0002018) | 2.09592464 |
| 73 | Acute hepatic failure (HP:0006554) | 2.07661042 |
| 74 | Impaired proprioception (HP:0010831) | 2.07193097 |
| 75 | Embryonal renal neoplasm (HP:0011794) | 2.06675023 |
| 76 | Hypoglycemic coma (HP:0001325) | 2.06225565 |
| 77 | Increased serum pyruvate (HP:0003542) | 2.05181559 |
| 78 | Abnormality of glycolysis (HP:0004366) | 2.05181559 |
| 79 | Abnormal spermatogenesis (HP:0008669) | 2.05110276 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.04386905 |
| 81 | Acanthocytosis (HP:0001927) | 2.03548989 |
| 82 | Nemaline bodies (HP:0003798) | 2.01851905 |
| 83 | Pallor (HP:0000980) | 2.00805781 |
| 84 | Biliary tract neoplasm (HP:0100574) | 2.00340903 |
| 85 | Lactic acidosis (HP:0003128) | 1.99821688 |
| 86 | Premature graying of hair (HP:0002216) | 1.99764830 |
| 87 | Postnatal microcephaly (HP:0005484) | 1.98900974 |
| 88 | Hepatic necrosis (HP:0002605) | 1.97919651 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 1.95982168 |
| 90 | Deviation of the thumb (HP:0009603) | 1.94331548 |
| 91 | Rimmed vacuoles (HP:0003805) | 1.93750651 |
| 92 | Cortical dysplasia (HP:0002539) | 1.93443790 |
| 93 | Megaloblastic anemia (HP:0001889) | 1.93301355 |
| 94 | Abnormal platelet volume (HP:0011876) | 1.92723879 |
| 95 | Proximal placement of thumb (HP:0009623) | 1.92445015 |
| 96 | Abnormal cartilage morphology (HP:0002763) | 1.92385665 |
| 97 | Horseshoe kidney (HP:0000085) | 1.92323840 |
| 98 | Pelvic girdle muscle weakness (HP:0003749) | 1.91835048 |
| 99 | Abnormal platelet function (HP:0011869) | 1.91284428 |
| 100 | Impaired platelet aggregation (HP:0003540) | 1.91284428 |
| 101 | Cutaneous melanoma (HP:0012056) | 1.91094412 |
| 102 | Neoplasm of the pancreas (HP:0002894) | 1.90725823 |
| 103 | Glossoptosis (HP:0000162) | 1.90660500 |
| 104 | Abnormality of serum amino acid levels (HP:0003112) | 1.90218705 |
| 105 | Hypolipoproteinemia (HP:0010981) | 1.90215239 |
| 106 | Macrocytic anemia (HP:0001972) | 1.90000140 |
| 107 | Microretrognathia (HP:0000308) | 1.89937306 |
| 108 | Methylmalonic acidemia (HP:0002912) | 1.88993030 |
| 109 | Poikilocytosis (HP:0004447) | 1.88985701 |
| 110 | Increased CSF lactate (HP:0002490) | 1.88785019 |
| 111 | Absent thumb (HP:0009777) | 1.88730628 |
| 112 | Sloping forehead (HP:0000340) | 1.88124701 |
| 113 | Ependymoma (HP:0002888) | 1.86598910 |
| 114 | Tongue fasciculations (HP:0001308) | 1.86429113 |
| 115 | Combined immunodeficiency (HP:0005387) | 1.85510234 |
| 116 | Hyperglycinuria (HP:0003108) | 1.82828360 |
| 117 | Abnormal biliary tract morphology (HP:0012440) | 1.82753133 |
| 118 | Trismus (HP:0000211) | 1.82743962 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.82454115 |
| 120 | Meckel diverticulum (HP:0002245) | 1.80915722 |
| 121 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80904974 |
| 122 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80549874 |
| 123 | Hepatocellular necrosis (HP:0001404) | 1.80445395 |
| 124 | Amaurosis fugax (HP:0100576) | 1.79632730 |
| 125 | Acute encephalopathy (HP:0006846) | 1.79313277 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 1.79048122 |
| 127 | Poikiloderma (HP:0001029) | 1.78361750 |
| 128 | Pancytopenia (HP:0001876) | 1.77537307 |
| 129 | Abnormality of lateral ventricle (HP:0030047) | 1.77180131 |
| 130 | T lymphocytopenia (HP:0005403) | 1.76461319 |
| 131 | Muscle fiber inclusion bodies (HP:0100299) | 1.75976732 |
| 132 | Abnormality of the labia minora (HP:0012880) | 1.74872625 |
| 133 | Prominent nose (HP:0000448) | 1.74629120 |
| 134 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.74610435 |
| 135 | Tetraparesis (HP:0002273) | 1.74461006 |
| 136 | Lymphoma (HP:0002665) | 1.74364181 |
| 137 | Abnormality of T cells (HP:0002843) | 1.74245524 |
| 138 | Abnormality of alanine metabolism (HP:0010916) | 1.73822130 |
| 139 | Hyperalaninemia (HP:0003348) | 1.73822130 |
| 140 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73822130 |
| 141 | Recurrent viral infections (HP:0004429) | 1.73529803 |
| 142 | Small intestinal stenosis (HP:0012848) | 1.73222859 |
| 143 | Duodenal stenosis (HP:0100867) | 1.73222859 |
| 144 | Exercise intolerance (HP:0003546) | 1.72226322 |
| 145 | Neoplasm of the colon (HP:0100273) | 1.71870283 |
| 146 | Abnormality of reticulocytes (HP:0004312) | 1.71580442 |
| 147 | Abnormality of glycine metabolism (HP:0010895) | 1.71198159 |
| 148 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.71198159 |
| 149 | Increased IgM level (HP:0003496) | 1.70390559 |
| 150 | Increased mean platelet volume (HP:0011877) | 1.69216487 |
| 151 | Recurrent abscess formation (HP:0002722) | 1.68650653 |
| 152 | Abnormality of methionine metabolism (HP:0010901) | 1.68552771 |
| 153 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.68201008 |
| 154 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67881252 |
| 155 | Missing ribs (HP:0000921) | 1.67651515 |
| 156 | Acute myeloid leukemia (HP:0004808) | 1.67493745 |
| 157 | Abnormal foot bone ossification (HP:0010675) | 1.67341501 |
| 158 | Abnormality of the ileum (HP:0001549) | 1.66863920 |
| 159 | Prolonged partial thromboplastin time (HP:0003645) | 1.66517372 |
| 160 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.66163883 |
| 161 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.66163883 |
| 162 | Metaphyseal cupping (HP:0003021) | 1.66069219 |
| 163 | Abnormality of T cell number (HP:0011839) | 1.65985252 |
| 164 | Facial hemangioma (HP:0000329) | 1.65832030 |
| 165 | Hyperammonemia (HP:0001987) | 1.63444892 |
| 166 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.62252129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.75954790 |
| 2 | CDC7 | 3.50694942 |
| 3 | EIF2AK1 | 3.43274179 |
| 4 | ACVR1B | 3.41308107 |
| 5 | NEK1 | 3.32579543 |
| 6 | NEK2 | 3.16454866 |
| 7 | WEE1 | 3.05706329 |
| 8 | TRIM28 | 2.72571859 |
| 9 | MST4 | 2.66634334 |
| 10 | SRPK1 | 2.49127966 |
| 11 | PLK4 | 2.23297723 |
| 12 | NUAK1 | 2.11905905 |
| 13 | NME1 | 2.09868065 |
| 14 | TTK | 2.02178205 |
| 15 | PBK | 1.90740052 |
| 16 | PKN2 | 1.85222987 |
| 17 | NME2 | 1.82436538 |
| 18 | EIF2AK3 | 1.82295188 |
| 19 | PDK2 | 1.80261124 |
| 20 | PLK1 | 1.76934417 |
| 21 | MKNK1 | 1.72790880 |
| 22 | AURKB | 1.71315468 |
| 23 | RPS6KA4 | 1.64262318 |
| 24 | BRSK2 | 1.63790316 |
| 25 | VRK1 | 1.58212963 |
| 26 | SIK3 | 1.56881137 |
| 27 | PLK3 | 1.56824892 |
| 28 | TGFBR1 | 1.53889503 |
| 29 | RPS6KB2 | 1.48301930 |
| 30 | IRAK3 | 1.46099905 |
| 31 | ERBB3 | 1.42705906 |
| 32 | ATR | 1.41835808 |
| 33 | TSSK6 | 1.39181350 |
| 34 | DYRK3 | 1.38124078 |
| 35 | VRK2 | 1.34527696 |
| 36 | STK10 | 1.33064707 |
| 37 | PASK | 1.32927093 |
| 38 | MAP2K3 | 1.32656312 |
| 39 | CDK7 | 1.26852056 |
| 40 | FLT3 | 1.26311950 |
| 41 | FGFR4 | 1.25804963 |
| 42 | TESK2 | 1.25455761 |
| 43 | MAP3K8 | 1.24821565 |
| 44 | SCYL2 | 1.24584090 |
| 45 | CDK4 | 1.23068283 |
| 46 | JAK3 | 1.22606375 |
| 47 | MKNK2 | 1.21670127 |
| 48 | EEF2K | 1.20387577 |
| 49 | STK4 | 1.17434326 |
| 50 | STK16 | 1.17379533 |
| 51 | MAP4K1 | 1.17187383 |
| 52 | TAF1 | 1.15916293 |
| 53 | CHEK2 | 1.15044865 |
| 54 | CDK12 | 1.13252286 |
| 55 | TLK1 | 1.12543905 |
| 56 | SMG1 | 1.05999817 |
| 57 | CHEK1 | 1.05722713 |
| 58 | ZAK | 1.04895540 |
| 59 | AURKA | 1.02987941 |
| 60 | BRD4 | 1.01167361 |
| 61 | BCR | 0.99940188 |
| 62 | MAP3K3 | 0.99140148 |
| 63 | KIT | 0.96905281 |
| 64 | MAPKAPK3 | 0.94923518 |
| 65 | TYK2 | 0.92120029 |
| 66 | PIM1 | 0.91634741 |
| 67 | PRPF4B | 0.91537466 |
| 68 | STK3 | 0.90648048 |
| 69 | TXK | 0.89224169 |
| 70 | STK24 | 0.87703624 |
| 71 | RAF1 | 0.86523969 |
| 72 | ATM | 0.81187345 |
| 73 | CDK6 | 0.78990670 |
| 74 | ERBB4 | 0.78404275 |
| 75 | BRSK1 | 0.78238055 |
| 76 | PAK4 | 0.76287247 |
| 77 | EPHA2 | 0.76082412 |
| 78 | MAP3K6 | 0.74759374 |
| 79 | IRAK4 | 0.74444600 |
| 80 | CDK19 | 0.73675691 |
| 81 | MAP3K14 | 0.72540565 |
| 82 | CDK2 | 0.72296026 |
| 83 | CCNB1 | 0.70627375 |
| 84 | FGFR3 | 0.70391752 |
| 85 | OBSCN | 0.69922148 |
| 86 | CLK1 | 0.68809185 |
| 87 | MELK | 0.68234519 |
| 88 | EIF2AK2 | 0.67732328 |
| 89 | MAPK11 | 0.64343217 |
| 90 | CSNK2A2 | 0.63587773 |
| 91 | MATK | 0.62209077 |
| 92 | CSNK1G3 | 0.61627082 |
| 93 | MAP3K10 | 0.61572637 |
| 94 | IRAK1 | 0.61126999 |
| 95 | MAP3K5 | 0.60908195 |
| 96 | BLK | 0.59872758 |
| 97 | STK38L | 0.58875338 |
| 98 | PIM2 | 0.58775711 |
| 99 | NEK9 | 0.57663436 |
| 100 | BCKDK | 0.57601648 |
| 101 | CSNK2A1 | 0.57590031 |
| 102 | TEC | 0.57486744 |
| 103 | IKBKE | 0.56823984 |
| 104 | PIK3CG | 0.56612416 |
| 105 | RPS6KA5 | 0.55821497 |
| 106 | IKBKB | 0.55293510 |
| 107 | TBK1 | 0.55141676 |
| 108 | CSNK1A1L | 0.53792896 |
| 109 | CDK9 | 0.52336102 |
| 110 | GRK6 | 0.52238553 |
| 111 | ZAP70 | 0.51703585 |
| 112 | ALK | 0.51531116 |
| 113 | CDK1 | 0.50793594 |
| 114 | MAP4K2 | 0.50272960 |
| 115 | FGR | 0.46863465 |
| 116 | CDK8 | 0.42955265 |
| 117 | BTK | 0.40532405 |
| 118 | MAP3K12 | 0.40341924 |
| 119 | BMPR2 | 0.40043466 |
| 120 | PAK1 | 0.39381819 |
| 121 | BMPR1B | 0.38585142 |
| 122 | CHUK | 0.38529980 |
| 123 | PRKCI | 0.37834850 |
| 124 | CSNK1G1 | 0.37171029 |
| 125 | AKT2 | 0.36378889 |
| 126 | IRAK2 | 0.35838713 |
| 127 | RPS6KB1 | 0.34728158 |
| 128 | LRRK2 | 0.33888902 |
| 129 | KDR | 0.33300366 |
| 130 | FGFR1 | 0.33037320 |
| 131 | SYK | 0.32042769 |
| 132 | CSNK1G2 | 0.31628319 |
| 133 | TAOK2 | 0.31462776 |
| 134 | RIPK4 | 0.31136518 |
| 135 | MARK3 | 0.30990196 |
| 136 | MTOR | 0.30656693 |
| 137 | BRAF | 0.29390929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.98884591 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.52192301 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.42403997 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.32304591 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.88145751 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.84648511 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.79389144 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.68098588 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.64453882 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.37615297 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.34626115 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.24964759 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.24085824 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.23525088 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.10392725 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.90657191 |
| 17 | RNA degradation_Homo sapiens_hsa03018 | 1.84115576 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72326402 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65022578 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53904959 |
| 21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.52913662 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51431030 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47573320 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.44741964 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43789011 |
| 26 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.42731999 |
| 27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.39395246 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.36697838 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.31369742 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29770522 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29292877 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26637446 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17845927 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17232056 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.17140156 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11036237 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10642949 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04795334 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03251858 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01038469 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98090525 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96125082 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95964761 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 0.95861272 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94855933 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92502467 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92068624 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91712830 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.87174435 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.85089726 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84745051 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81972250 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81245068 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70873869 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68880209 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68279276 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67874064 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66544043 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61323556 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60941190 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57761286 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54492340 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54020377 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53837515 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52778389 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52640293 |
| 67 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52310032 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51165452 |
| 69 | Measles_Homo sapiens_hsa05162 | 0.50981413 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50858019 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49483905 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48832848 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48791638 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48145942 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46480503 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46105751 |
| 77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45659637 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45235143 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.45110057 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.44846471 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44493693 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43059178 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.42520358 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42024515 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41902317 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40398186 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.39808088 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36837314 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36419525 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.35562870 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35524806 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.35185320 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34510740 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33754046 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33514877 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33279712 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.32758287 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32485663 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31125081 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31064886 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30939440 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29107503 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27671251 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.27214463 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27047787 |
| 106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26721859 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26105352 |
| 108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26006218 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25331163 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.24947547 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24678904 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24414229 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24331098 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23640068 |
| 115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.22286394 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22220665 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20145571 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.18838905 |
| 119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.18650791 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17931705 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.17726052 |

